Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC).

Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC). Expert Rev Anticancer Ther. 2019 Apr 05;: Authors: Tan AC, Teh YL, Lai GGY, Tan DSW PMID: 30950666 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30950666?dopt=Abstract

Source: Expert Review of Anticancer Therapy - April 7, 2019 Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer